Dipartimento Di Scienze Farmacologiche E Biomolecolari, University of Milan, Via Vanvitelli 32, 20129, Milano, Italy.
Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126, Parma, Italy.
Psychopharmacology (Berl). 2023 Oct;240(10):2131-2146. doi: 10.1007/s00213-023-06436-1. Epub 2023 Aug 2.
Asteoarthritis (OA) is a leading cause of chronic pain in the elderly population and is often associated with emotional comorbidities such as anxiety and depression. Despite age is a risk factor for both OA and mood disorders, preclinical studies are mainly conducted in young adult animals.
Here, using young adult (11-week-old) and older adult (20-month-old) mice, we evaluate in a monosodium-iodoacetate-(MIA)-induced OA model the development of anxio-depressive-like behaviors and whether brain neuroinflammation may underlie the observed changes. We also test whether an effective pain treatment may prevent behavioral and biochemical alterations.
Mechanical allodynia was monitored throughout the experimental protocol, while at the end of protocol (14 days), anxio-depressive-like behaviors and cognitive dysfunction were assessed. Neuroinflammatory condition was evaluated in prefrontal cortex, hippocampus and hypothalamus. Serum IFNγ levels were also measured. Moreover, we test the efficacy of a 1-week treatment with morphine (2.5 mg/kg) on pain, mood alterations and neuroinflammation.
We observed that young adult and older adult controls (CTRs) mice had comparable allodynic thresholds and developed similar allodynia after MIA injection. Older adult CTRs were characterized by altered behavior in the tests used to assess the presence of depression and cognitive impairment and by elevated neuroinflammatory markers in brain areas compared to younger ones. The presence of pain induced depressive-like behavior and neuroinflammation in adult young mice, anxiety-like behavior in both age groups and worsened neuroinflammation in older adult mice. Morphine treatment counteracted pain, anxio-depressive behaviors and neuroinflammatory activation in both young adult and older adult mice.
Here, we demonstrated that the presence of chronic pain in young adult mice induces mood alterations and supraspinal biochemical changes and aggravates the alterations already evident in older adult animals. A treatment with morphine, counteracting the pain, prevents the development of anxio-depressive disorders and reduces neuroinflammation.
骨关节炎(OA)是老年人群慢性疼痛的主要原因,常伴有焦虑和抑郁等情绪共病。尽管年龄是 OA 和情绪障碍的共同危险因素,但临床前研究主要在年轻成年动物中进行。
本研究使用年轻成年(11 周龄)和老年(20 月龄)小鼠,在碘乙酸单钠(MIA)诱导的 OA 模型中评估焦虑抑郁样行为的发展,以及脑神经炎症是否是观察到的变化的基础。我们还测试了有效的疼痛治疗是否可以预防行为和生化改变。
在整个实验过程中监测机械性触诱发痛,在实验结束时(14 天),评估焦虑抑郁样行为和认知功能障碍。评估前额叶皮层、海马体和下丘脑的神经炎症状况。还测量了血清 IFNγ 水平。此外,我们测试了吗啡(2.5mg/kg)1 周治疗对疼痛、情绪改变和神经炎症的疗效。
我们发现,年轻成年和老年对照组(CTR)小鼠的触诱发痛阈值相当,在 MIA 注射后出现类似的触诱发痛。与年轻小鼠相比,老年 CTR 小鼠在评估抑郁和认知障碍存在的测试中表现出行为改变,并且大脑区域的神经炎症标志物水平升高。疼痛导致年轻成年小鼠出现抑郁样行为和神经炎症,在两个年龄组中出现焦虑样行为,在老年成年小鼠中加重神经炎症。吗啡治疗可缓解年轻成年和老年成年小鼠的疼痛、焦虑抑郁样行为和神经炎症激活。
本研究表明,慢性疼痛的存在会诱导年轻成年小鼠的情绪改变和中枢神经系统生化改变,并加重老年成年动物已经存在的改变。吗啡治疗,缓解疼痛,可预防焦虑抑郁障碍的发生,并减轻神经炎症。